左旋多巴诱导的运动障碍与帕金森病额叶执行功能进展密切相关
这项回顾性队列研究纳入119例接受左旋多巴治疗超过5年的帕金森病患者,根据5年内是否出现左旋多巴诱导的运动障碍(LID)分为PD-LID+组(n=38)和PD-LID-组(n=81)。调整年龄、性别、教育年限、体重指数、基线运动严重程度和每年左旋多巴增量后,PD-LID+组额叶执行功能和整体认知功能下降更快,痴呆转化率显著更高(调整HR 3.94,95%CI 1.76-8.82)。
要点
- LID出现与帕金森病认知下降进展相关,尤其是额叶执行功能。
- PD-LID+组痴呆转化率显著高于PD-LID-组(调整HR 3.94)。
- PD-LID+合并MCI者痴呆转化风险进一步升高。
核心结论
- LID与帕金森病认知下降进展密切相关,尤其是额叶执行功能障碍和帕金森病痴呆的发生。
研究设计与样本
- 回顾性队列研究,纳入119例接受左旋多巴治疗超过5年且完成基线和随访神经心理评估的帕金森病患者。
- 根据左旋多巴给药5年内是否出现LID,分为PD-LID+组(n=38)和PD-LID-组(n=81)。
主要发现
- 基线的神经心理表现和轻度认知障碍(MCI)患者比例在两组间无差异。
- PD-LID+组额叶执行功能(p=0.002)和整体认知功能下降更快。
- PD-LID+组痴呆转化率显著高于PD-LID-组(调整HR 3.94,95%CI 1.76-8.82)。
- PD-LID+组合并MCI者痴呆转化风险高于PD-LID-组认知正常者(调整HR 6.08,95%CI 1.25-29.56)和PD-LID-组合并MCI者(调整HR 4.05,95%CI 1.14-14.43)。
临床怎么用
- 对出现LID的帕金森病患者应关注认知功能,尤其是额叶执行功能,并警惕痴呆转化风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the relationship between the development of levodopa-induced dyskinesia (LID) and longitudinal changes in cognition. METHODS: In this retrospective cohort study, we recruited 119 patients with Parkinson disease (PD) who underwent baseline and follow-up neuropsychological evaluations and were treated with levodopa for >5 years. On the basis of LID development, the patients were classified as patients with LID (PD-LID+, n = 38) or without LID (PD-LID-, n = 81) within 5 years of levodopa administration. After adjusting for age, sex, years of education, body mass index, motor severity at baseline, and levodopa increment per year, we compared the rates of cognitive decline using linear mixed model and dementia conversion using survival analysis between the groups. RESULTS: Neuropsychological performances and the percentage of patients with mild cognitive impairment (MCI) at baseline did not differ between the groups. The PD-LID+ group showed faster declines in frontal executive function (p = 0.002) and global cognitive function. The conversion rate to dementia was significantly higher in the PD-LID+ group than in the PD-LID- group (adjusted hazard ratio [HR] 3.94, 95% confidence interval [CI] 1.76-8.82). Patients with MCI in the PD-LID+ group had a higher risk of PD dementia conversion than those with normal cognition (adjusted HR 6.08, 95% CI 1.25-29.56) or MCI (adjusted HR 4.05, 95% CI 1.14-14.43) in the PD-LID- group. CONCLUSIONS: These results demonstrated that LID was closely associated with the progression of cognitive decline, especially frontal executive dysfunction, and the development of PD dementia.
引用
- Yoo HS, Chung SJ, Lee YH, et al. Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD. Neurology. 2019. PMID: 30796137. doi:10.1212/WNL.0000000000007189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。